The major roles of the Molecular Biology Core are (1) to provide services in the utilization of molecular biologicaltechniques and (2) to facilitate the implementation of advances in molecular biology to IBD research. Applicationof molecular biological approaches is central to the evaluation of processes underlying the development of IBDaccording to the hypotheses that serve as a foundation for this Center. These approaches include evaluation of themechanisms for maintaining epithelial function and integrity, factors regulating immune activation and processescontributing to amplification of inflammatory responses and tissue injury [1]. Most importantly, molecularbiological approaches are essential in the study of innate immunity, host:microbial interactions at the mucosalinterface, dendritic cell/immune cell interactions, human genetic evaluation and murine models of IBD, areaswhich form key components of IBD-related research in the next support period[2-8]. It is apparent from thedescription of the CSIBD research base that most Center investigators use basic molecular biological techniques as afundamental component of their research projects. These techniques permit the identification and characterization ofgenes regulating epithelial and immune cell function, analysis of the expression of these genes, determination of thefunctions aid interactions of tie encoded proteins, expression of reporter genes and proteins to allow cellular localization and physiological analysis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK043351-16
Application #
7002016
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M1))
Project Start
2006-01-01
Project End
2010-12-31
Budget Start
2006-01-01
Budget End
2006-12-31
Support Year
16
Fiscal Year
2006
Total Cost
$157,250
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Ganna, Andrea; Satterstrom, F Kyle; Zekavat, Seyedeh M et al. (2018) Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum. Am J Hum Genet 102:1204-1211
Vandoorne, Katrien; Rohde, David; Kim, Hye-Yeong et al. (2018) Imaging the Vascular Bone Marrow Niche During Inflammatory Stress. Circ Res 123:415-427
Cai, Tianrun; Lin, Tzu-Chieh; Bond, Allison et al. (2018) The Association Between Arthralgia and Vedolizumab Using Natural Language Processing. Inflamm Bowel Dis 24:2242-2246
Sayeed, Md Abu; Islam, Kamrul; Hossain, Motaher et al. (2018) Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools. PLoS Negl Trop Dis 12:e0006286
Maehara, Takashi; Mattoo, Hamid; Mahajan, Vinay S et al. (2018) The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching in vivo. Life Sci Alliance 1:
Kearney, Sean M; Gibbons, Sean M; Poyet, Mathilde et al. (2018) Endospores and other lysis-resistant bacteria comprise a widely shared core community within the human microbiota. ISME J 12:2403-2416
Islam, Kamrul; Hossain, Motaher; Kelly, Meagan et al. (2018) Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. PLoS Negl Trop Dis 12:e0006376
Lidofsky, Anna; Holmes, Jacinta A; Feeney, Eoin R et al. (2018) Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis 218:1394-1403
Kruger, Annie J; Fuchs, Bryan C; Masia, Ricard et al. (2018) Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis. Hepatol Commun 2:529-545
Moran, Christopher J; Huang, Hailiang; Rivas, Manuel et al. (2018) Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. PLoS One 13:e0192806

Showing the most recent 10 out of 1166 publications